Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials (2023)
Attributed to:
Method Meta-analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(23)00230-9
Publication URI: http://dx.doi.org/10.1016/s1470-2045(23)00230-9
Type: Journal Article/Review
Parent Publication: The Lancet Oncology
Issue: 7